Biohit Acquires Rights To H. Pylori Quick Test – New Superior Test To Product Range During Q4

Published: Nov 18, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biohit Oyj acquires the rights to the UFT300 test, which is a rapid test for the diagnosis of Helicobacter pylori infection. Along with the agreement, the Italian developer, Advanced Biomedical Systems s.r.l. (ABS) gives Biohit the patent and distribution rights for the test. The purchase price is EUR 350,000 and the new H. pylori quick test will be incorporated into Biohit’s product range during the fourth quarter, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news